Viatris Innovation Gmbh

This study tests a new drug, cenerimod, for adults with moderate-to-severe systemic lupus erythematosus (SLE). About 470 participants will receive either cenerimod or a placebo on top of their usual treatments for 12 months. The goal is to see if cenerimod can better control lupu…

This study tests whether adding cenerimod to standard lupus treatments can better control moderate-to-severe symptoms. About 451 adults with lupus will receive either cenerimod or a placebo for 12 months. The goal is to see if cenerimod reduces disease activity without causing se…

This study tests a drug called selatogrel that people with a recent heart attack can inject themselves at home. The goal is to see if it can prevent death or reduce damage if another heart attack happens. About 25,000 participants will be randomly assigned to receive either the d…

This study looks at the long-term safety of cenerimod in adults with moderate-to-severe lupus. About 680 people who already completed a year-long study will take cenerimod for up to 3 more years, along with their usual lupus medications. Researchers will track side effects and se…